Literature DB >> 16612617

Persistent dysfunctional frontal lobe activation in former smokers.

Andres Neuhaus1, Malek Bajbouj, Thorsten Kienast, Peter Kalus, Dorothea von Haebler, Georg Winterer, Jürgen Gallinat.   

Abstract

OBJECTIVE: Chronic smoking and nicotine exposure are accompanied by impaired cognitive task performance, modulated cerebral activity in brain imaging studies, and neuritic damage in experimental animals. The profile of the described dysfunctions matches frontal lobe circuits which also play a role in reward processing and reinforcement behavior. However, it is largely unknown if cerebral dysfunctions are reversible or persist during long term abstinence.
MATERIALS AND METHODS: Cortical activation during auditory target processing (oddball task, P300 component) was recorded with 32-channel EEG in 247 healthy subjects consisting of 84 smokers, 53 former smokers (mean time of abstinence 11.9 years), and 110 never smokers.
RESULTS: Both current smokers and former smokers exhibited significantly diminished P300 amplitudes (Cz, Pz) relative to never smokers. Neuroelectric source analysis (low resolution brain electromagnetic tomography) revealed a hypoactivation of the anterior cingulate, orbitofrontal, and prefrontal cortex in smokers compared to never smokers. A similar profile of hypoactivation was observed in former smokers.
CONCLUSION: For the first time, evidence is provided that dysfunctional activation of frontal lobe networks in smokers is also present in long term abstainers.

Entities:  

Mesh:

Year:  2006        PMID: 16612617     DOI: 10.1007/s00213-006-0366-7

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  68 in total

1.  Abstract reward and punishment representations in the human orbitofrontal cortex.

Authors:  J O'Doherty; M L Kringelbach; E T Rolls; J Hornak; C Andrews
Journal:  Nat Neurosci       Date:  2001-01       Impact factor: 24.884

2.  Smoking history and nicotine effects on cognitive performance.

Authors:  M Ernst; S J Heishman; L Spurgeon; E D London
Journal:  Neuropsychopharmacology       Date:  2001-09       Impact factor: 7.853

3.  Prefrontal activation evoked by infrequent target and novel stimuli in a visual target detection task: an event-related functional magnetic resonance imaging study.

Authors:  E Kirino; A Belger; P Goldman-Rakic; G McCarthy
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

4.  Differences between smokers and nonsmokers in regional gray matter volumes and densities.

Authors:  Arthur L Brody; Mark A Mandelkern; Murray E Jarvik; Grace S Lee; Erlyn C Smith; Joe C Huang; Robert G Bota; George Bartzokis; Edythe D London
Journal:  Biol Psychiatry       Date:  2004-01-01       Impact factor: 13.382

5.  Emotion-attention network interactions during a visual oddball task.

Authors:  Harlan M Fichtenholtz; Heather L Dean; Daniel G Dillon; Hiroshi Yamasaki; Gregory McCarthy; Kevin S LaBar
Journal:  Brain Res Cogn Brain Res       Date:  2004-06

6.  Serotonergic effects of smoking are independent from the human serotonin transporter gene promoter polymorphism: evidence from auditory cortical stimulus processing.

Authors:  J Gallinat; D Kunz; U E Lang; P Kalus; G Juckel; J Eggers; R Mahlberg; M Staedtgen; C Wernicke; H Rommelspacher; M N Smolka
Journal:  Pharmacopsychiatry       Date:  2005-07       Impact factor: 5.788

7.  Dramatic decreases in brain reward function during nicotine withdrawal.

Authors:  M P Epping-Jordan; S S Watkins; G F Koob; A Markou
Journal:  Nature       Date:  1998-05-07       Impact factor: 49.962

Review 8.  Nonparametric analysis of statistic images from functional mapping experiments.

Authors:  A P Holmes; R C Blair; J D Watson; I Ford
Journal:  J Cereb Blood Flow Metab       Date:  1996-01       Impact factor: 6.200

9.  The P300 brain potential is reduced in smokers.

Authors:  A P Anokhin; A B Vedeniapin; E J Sirevaag; L O Bauer; S J O'Connor; S Kuperman; B Porjesz; T Reich; H Begleiter; J Polich; J W Rohrbaugh
Journal:  Psychopharmacology (Berl)       Date:  2000-05       Impact factor: 4.530

Review 10.  Alcohol consumption and abnormalities of brain structure and vasculature.

Authors:  Kenneth J Mukamal
Journal:  Am J Geriatr Cardiol       Date:  2004 Jan-Feb
View more
  17 in total

Review 1.  How human electrophysiology informs psychopharmacology: from bottom-up driven processing to top-down control.

Authors:  J Leon Kenemans; Seppo Kähkönen
Journal:  Neuropsychopharmacology       Date:  2010-10-06       Impact factor: 7.853

2.  Chronic cigarette smoking and heavy drinking in human immunodeficiency virus: consequences for neurocognition and brain morphology.

Authors:  Timothy C Durazzo; Johannes C Rothlind; Valerie A Cardenas; Colin Studholme; Michael W Weiner; Dieter J Meyerhoff
Journal:  Alcohol       Date:  2007-10-17       Impact factor: 2.405

3.  Acute effects of methadone on EEG power spectrum and event-related potentials among heroin dependents.

Authors:  Farid Motlagh; Fatimah Ibrahim; Rusdi Rashid; Niusha Shafiabady; Tahereh Seghatoleslam; Hussain Habil
Journal:  Psychopharmacology (Berl)       Date:  2018-10-11       Impact factor: 4.530

4.  Effects of chronic nicotine, nicotine withdrawal and subsequent nicotine challenges on behavioural inhibition in rats.

Authors:  K Z Kolokotroni; R J Rodgers; A A Harrison
Journal:  Psychopharmacology (Berl)       Date:  2011-11-29       Impact factor: 4.530

5.  Cigarette smoking and the onset and persistence of depression among adults in the United States: 1994-2005.

Authors:  Jafar Bakhshaie; Michael J Zvolensky; Renee D Goodwin
Journal:  Compr Psychiatry       Date:  2014-10-23       Impact factor: 3.735

6.  Spatiotemporal mapping of sex differences during attentional processing.

Authors:  Andres H Neuhaus; Carolin Opgen-Rhein; Carsten Urbanek; Melanie Gross; Eric Hahn; Thi Minh Tam Ta; Simone Koehler; Michael Dettling
Journal:  Hum Brain Mapp       Date:  2009-09       Impact factor: 5.038

Review 7.  Recent EEG and ERP findings in substance abusers.

Authors:  Natalie A Ceballos; Lance O Bauer; Rebecca J Houston
Journal:  Clin EEG Neurosci       Date:  2009-04       Impact factor: 1.843

Review 8.  Neurophysiological biomarkers for drug development in schizophrenia.

Authors:  Daniel C Javitt; Kevin M Spencer; Gunvant K Thaker; Georg Winterer; Mihály Hajós
Journal:  Nat Rev Drug Discov       Date:  2008-01       Impact factor: 84.694

9.  Patterns of change in withdrawal symptoms, desire to smoke, reward motivation and response inhibition across 3 months of smoking abstinence.

Authors:  Lynne Dawkins; Jane H Powell; Alan Pickering; John Powell; Robert West
Journal:  Addiction       Date:  2009-03-13       Impact factor: 6.526

Review 10.  Going up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia.

Authors:  Douglas L Boggs; Jon Carlson; Jose Cortes-Briones; John H Krystal; D Cyril D'Souza
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.